Nifty MidSmall Healthcare's PB is cheaper than 51% of the last 3 years.
Not enough history for a 5Y percentile, showing 3Y instead.
The Nifty MidSmall Healthcare PE ratio is 47.08 as of 19 November 2026, about 3% above its 3-year median of 45.81, which places it in fairly valued territory on a historical basis.
| Period | Median PE | Current vs Median |
|---|---|---|
| 3 Years | 45.81 | +2.77% |
| 1 Year | 43.06 | +9.32% |
Series start. P/E is published from 3 Aug 2022. Index values go back to 1 Apr 2005.
Index earnings are the profits behind the index level: the closing value divided by the P/E ratio, in index points. The line moves in steps because it changes only when trailing four-quarter profits are updated or the constituents change. Compare it with price to see whether a move came from earnings or from a change in what investors pay for them.
Nifty MidSmall Healthcare earnings grew +20.45% a year over the last 3 years, while the index moved +24.25% a year and its P/E went from 42.9 to 47.1.
Earnings growth is annualised from the last trading day at or before the start of each window to 19 Nov 2026. Price growth uses the index level over the same two dates, excluding dividends. EPS is undefined on days with no published P/E, so those days are skipped. Past growth, not a forecast.
0 ETFs and 2 index funds track this index. Prices and NAVs as of 18 Nov 2026.
| Fund | AMC | NAV | Since |
|---|---|---|---|
| Tata Nifty MidSmall Healthcare Index Fund | Tata Asset Management Private Limited | 15.7518 Nov 2026 | 2024 |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund | Motilal Oswal Asset Management Company Limited | 12.9518 Nov 2026 | 2024 |
Listed for information only, not a recommendation. Check expense ratio and tracking difference before investing.
1-year holding windows since 2022 returned a median of +22.56% (best +74.21%, worst -1.49%).
View full performance and risk
Returns as of October 2026, from the NSE factsheet for the Nifty MidSmall Healthcare. 1-year returns are absolute; 5-year returns are annualized.
The Nifty MidSmall Healthcare contains 30 constituents.
4 October 2026: Added Anthem Biosciences Ltd.. Removed Pfizer Ltd..
23 July 2026: Added Acutaas Chemicals Ltd.. Removed J.B. Chemicals & Pharmaceuticals Ltd..
Constituent list as of 15 November 2026, sourced from NSE Indices. Weights as of 30 October 2026, from the NSE factsheet.
Get weekly market insights and valuation updates delivered to your inbox.
As of 19 November 2026, the Nifty MidSmall Healthcare PE ratio is 47.08. That is about 3% above its 3-year median of 45.81 and about 9% above its 1-year median of 43.06.
On a historical basis it screens as fairly valued. Its current PE of 47.08 sits above every median window: 1-year (43.06) and 3-year (45.81).
Over the past three years its median PE has been 45.81, and over the past one year 43.06. Today's 47.08 is toward the upper end of that historical range.
The Nifty MidSmall Healthcare contains 30 stocks. By number of companies, its largest sectors are Healthcare (30 stocks).
As of October 2026, the Nifty MidSmall Healthcare total return (with dividends reinvested) is +18.18% over the past year and +17.72% annualized over the past five years. One-year figures are absolute; multi-year figures are annualized (CAGR). Data from the NSE factsheet.
Over the year to October 2026, the Nifty MidSmall Healthcare had an annualized volatility (standard deviation of daily returns) of 15.38%. Its beta versus the Nifty 50 is 0.62, meaning it has moved less than the broad market.
Across every one-year holding window since 2022, the Nifty MidSmall Healthcare total return has a median of +22.56%, with the best window at +74.21% and the worst at -1.49%. Based on NSE Total Returns Index data; a past distribution, not a prediction.
Nifty MidSmall Healthcare earnings, measured as the index level divided by its P/E, grew +20.45% a year over the last 3 years, while the index itself moved +24.25% a year and its P/E rose from 42.88 to 47.08. Past growth, not a forecast.
Last updated: 19 November 2026.